Table 2 Utilization ratios of drugs in older CAD/CHF patients with and without low GFR
Diseases | Drugs | All | Without low GFR | With low GFR | P value* |
|---|---|---|---|---|---|
CAD | Aspirin (%) | 537 (51.1) | 355 (52.4) | 182 (48.9) | 0.287 |
Clopidogrel (%) | 622 (59.2) | 409 (60.3) | 213 (57.3) | 0.333 | |
Beta-blockers (%) | 705 (67.1) | 445 (65.6) | 260 (69.9) | 0.160 | |
CCBs (%) | 664 (63.2) | 410 (60.5) | 254 (68.3) | 0.012 | |
Nitrates (%) | 871 (83.0) | 558 (82.3) | 313 (84.1) | 0.449 | |
ACEI/ARBs (%) | 530 (50.5) | 346 (51.0) | 184 (49.5) | 0.626 | |
Statins (%) | 693 (66.0) | 453 (66.8) | 240 (64.5) | 0.452 | |
CHF | Beta-blockers (%) | 252 (77.1) | 117 (73.6) | 135 (80.4) | 0.145 |
ACEI/ARBs (%) | 178 (54.4) | 92 (57.9) | 86 (51.2) | 0.626 | |
Statins (%) | 214 (65.4) | 105 (66.0) | 109 (64.9) | 0.826 | |
Digoxin (%) | 168 (51.4) | 76 (47.8) | 92 (54.8) | 0.208 |